The Patient-Centered Outcomes Research Institute (“Awarding Agency” or “PCORI”), has engagedDuke to serve as the Coordinating Center for an investigator-sponsored, PCORI-funded program of clinical research involving human subjects entitled: “Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial” also referred to as “HERO HCQ Trial. DUKE hall establish and manage the Data Monitoring Committee (“DMC”) for the Study. Member desires to participate in the DMC Project as represented by its full-time faculty member, Clyde Yancy, MD.
|Effective start/end date||4/20/20 → 3/31/21|
- Duke University (Agmt 5/13/2020)
- Patient-Centered Outcomes Research Institute (Agmt 5/13/2020)